Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-07-03

Clinical Trial Update: Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer [NA]

View source ↗

Summary

A clinical trial evaluating omega-3 fatty acids for Stage III prostate cancer has been withdrawn (NCT00996749), sponsored by Wake Forest University Health Scien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Stage III Prostate Cancer | NA | Status: WITHDRAWN